Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA138125 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small cell lung cancer
| PRJNA122373 | ENA
Project description:Circulating microRNAs as non-invasive biomarkers for early detection of non-small-cell lung cancer
| PRJNA271363 | ENA
Project description:Angiogenesis is regarded as a hallmark in cancer development, and anti-angiogenic treatment is presently used in non-small cell lung cancer (NSCLC) patients. MicroRNAs (miRs) are small non-coding, endogenous, single stranded RNAs that regulate gene expression. As miRs are relatively stabile and measurable in both tissue and serum, they are potential prognostic and predictive markers. In this study we aimed to identify significant altered miRs related to angiogenesis in NSCLC
2011-03-08 | GSE27705 | GEO
Project description:microRNA dysregulation is a common feature of cancer cells, but the complex roles of microRNAs in cancer are not fully elucidated. Here we used functional genomics to identify oncogenic microRNAs in non-small cell lung cancer and to evaluate their impact on response to EGFR targeting therapy. Our data demonstrate that microRNAs with an AAGUGC-motif in their seed-sequence increase both cancer cell proliferation and sensitivity to EGFR inhibitors. Global transcriptomics, proteomics and target prediction resulted in the identification of several tumor suppressors involved in the G1/S transition as targets of AAGUGC-microRNAs. The clinical implications of our findings were evaluated by analysis of public domain data supporting the link between this microRNA seed-family, their tumor suppressor targets and cancer cell proliferation. In conclusion we propose that AAGUGC-microRNAs are an integral part of an oncogenic signaling network, and that these findings have potential therapeutic implications, especially in selecting patients for EGFR-targeting therapy.
2017-03-31 | MSV000080829 | MassIVE
Project description:A Gene Expression Signature to Predict Metastasis and Survival in Non-small Cell Lung Cancer
| PRJNA95773 | ENA
Project description:Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer
| PRJNA112051 | ENA
Project description:Prognostic Gene Expression Signature of Carcinoma Associated Fibroblasts in Non-Small Cell Lung Cancer [methylation profiling]
| PRJNA137327 | ENA
Project description:A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer
| PRJNA99683 | ENA